Antineoplastic AgentsProstateProstatic NeoplasmsProstate-Specific AntigenCell Line, TumorAntineoplastic Agents, PhytogenicLeukemia P388Receptors, AndrogenAndrogensDrug Screening Assays, AntitumorTumor Cells, CulturedAndrogen AntagonistsAmaryllidaceae AlkaloidsProstatectomyNeoplasmsApoptosisEllipticinesNarcissusBibenzylsDoxorubicinAntibiotics, AntineoplasticMice, NudeProstatic HyperplasiaGene Expression Regulation, NeoplasticCell SurvivalXenograft Model Antitumor AssaysCell ProliferationOrchiectomyNeoplasms, Hormone-DependentAntineoplastic Agents, AlkylatingBryostatinsThiadiazinesPaclitaxelDrug Resistance, NeoplasmDrug SynergismCisplatinEarly Detection of CancerAdenocarcinomaNeoplasm MetastasisCell DivisionNeoplasm TransplantationTumor Markers, BiologicalDisease ProgressionBreast NeoplasmsDose-Response Relationship, DrugAncitabineAntineoplastic Combined Chemotherapy ProtocolsLung NeoplasmsProstatic Intraepithelial NeoplasiaGalliumDepsipeptidesRNA, MessengerBone NeoplasmsTosyl CompoundsCell CycleOvarian NeoplasmsFluorouracilEpothilonesNeoplasm Invasiveness6-MercaptopurineNeoplasm GradingAntimetabolites, AntineoplasticAntineoplastic Agents, HormonalTaxoidsColonic NeoplasmsNeoplasm StagingNeoplasm ProteinsAminoacridinesMolecular StructureReverse Transcriptase Polymerase Chain ReactionTime FactorsGenetic Predisposition to DiseaseAndrogen Receptor AntagonistsSarcoma 180PrognosisLactonesEnzyme InhibitorsRisk FactorsTransplantation, HeterologousDigital Rectal ExaminationProdrugsAnilidesBlotting, WesternDrug Evaluation, PreclinicalEtoposideTreatment OutcomeClinical Trials as TopicLeukemia L1210Watchful WaitingNeoplasms, ExperimentalDihydrotestosteroneDaunorubicinDrug Administration ScheduleImmunohistochemistryFinasterideCarcinomaSignal TransductionBleomycinStilbenesCase-Control Studies